Clinical Trial Update: Naltrexone for Prolonged Grief Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating naltrexone HCl 50 mg for prolonged grief disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prolonged Grief Disorder

Drugs mentioned

• Naltrexone HCl 50 MG Oral Tablet (naltrexone hydrochloride)

Snippet

Sponsor: Texas Tech University | Conditions: Naltrexone HCl 50 MG Oral Tablet, Placebo | Phase 4 | Status: TERMINATED